Less Ads, More Data, More Tools Register for FREE

Pin to quick picksDNK.L Regulatory News (DNK)

  • There is currently no data for DNK

Appendix 5B

30 Oct 2020 07:05

RNS Number : 6370D
Danakali Limited
30 October 2020
Β 

Appendix 5B

Mining exploration entity or oil and gas exploration entityquarterly cash flow report

Name of entity

Danakali Limited

ABN

Β 

Quarter ended ("current quarter")

57 097 904 302

30 September 2020

Β 

Consolidated statement of cash flows

Current quarter$A'000

Year to date (9 months)$A'000

1.

Cash flows from operating activities

-

-

1.1

Receipts from customers

1.2

Payments for

-

-

(a) exploration & evaluation

(b) development

-

-

(c) production

-

-

(d) staff costs

(304)

(800)

(e) administration and corporate costs

(496)

(1,793)

1.3

Dividends received (see noteΒ 3)

-

-

1.4

Interest received

8

70

1.5

Interest and other costs of finance paid

-

-

1.6

Income taxes paid

-

-

1.7

Government grants and tax incentives

55

105

1.8

Other (provide details if material)

-

-

1.9

Net cash from / (used in) operating activities

(737)

(2,418)

2.

Cash flows from investing activities

-

-

2.1

Payments to acquire or for:

(a) entities

(b) tenements

-

-

(c) property, plant and equipment

-

-

(d) exploration & evaluation

-

-

(e) investments

-

-

(f) other non-current assets

-

-

2.2

Proceeds from the disposal of:

-

-

(a) entities

(b) tenements

-

-

(c) property, plant and equipment

-

-

(d) investments

-

-

(e) other non-current assets

-

-

2.3

Cash flows from loans to other entities

-

-

2.4

Dividends received (see noteΒ 3)

-

-

2.5

Other (funding of joint venture)

(2,097)*

(16,055)

2.6

Net cash from / (used in) investing activities

(2,097)

(16,055)

3.

Cash flows from financing activities

-

-

3.1

Proceeds from issues of equity securities (excluding convertible debt securities)

3.2

Proceeds from issue of convertible debt securities

-

-

3.3

Proceeds from exercise of options

-

-

3.4

Transaction costs related to issues of equity securities or convertible debt securities

-

(3,326)

3.5

Proceeds from borrowings

-

-

3.6

Repayment of borrowings

-

-

3.7

Transaction costs related to loans and borrowings

-

-

3.8

Dividends paid

-

-

3.9

Other (provide details if material)

-

-

3.10

Net cash from / (used in) financing activities

-

(3,326)

4.

Net increase / (decrease) in cash and cash equivalents for the period

4.1

Cash and cash equivalents at beginning of period

15,771

33,800

4.2

Net cash from / (used in) operating activities (itemΒ 1.9 above)

(737)

(2,418)

4.3

Net cash from / (used in) investing activities (itemΒ 2.6 above)

(2,097)

(16,055)

4.4

Net cash from / (used in) financing activities (itemΒ 3.10 above)

-

(3,326)

4.5

Effect of movement in exchange rates on cash held

(558)

378

4.6

Cash and cash equivalents at end of period

12,379

12,379

Β 

5.

Reconciliation of cash and cash equivalentsat the end of the quarter (as shown in the consolidated statement of cash flows) to the related items in the accounts

Current quarter$A'000

Previous quarter$A'000

5.1

Bank balances

12,379

8,501

5.2

Call deposits

-

-

5.3

Bank overdrafts

-

-

5.4

Other (term deposit)

-

7,270

5.5

Cash and cash equivalents at end of quarter (should equal itemΒ 4.6 above)

12,379

15,771

Β 

6.

Payments to related parties of the entity and their associates

Current quarter$A'000

6.1

Aggregate amount of payments to related parties and their associates included in itemΒ 1

104

6.2

Aggregate amount of payments to related parties and their associates included in itemΒ 2

-

Note: if any amounts are shown in items 6.1 or 6.2, your quarterly activity report must include a description of, and an explanation for, such payments.

Payments included in item 6.1 relates to payment of director fees ($104k)

7.

Financing facilitiesNote: the term "facility' includes all forms of financing arrangements available to the entity.

Add notes as necessary for an understanding of the sources of finance available to the entity.

Total facility amount at quarter end$A'000

Amount drawn at quarter end$A'000

7.1

Loan facilities

-

-

7.2

Credit standby arrangements

-

-

7.3

Other (please specify)

-

-

7.4

Total financing facilities

-

-

7.5

Unused financing facilities available at quarter end

-

7.6

Include in the box below a description of each facility above, including the lender, interest rate, maturity date and whether it is secured or unsecured. If any additional financing facilities have been entered into or are proposed to be entered into after quarter end, include a note providing details of those facilities as well.

Β 

Β 

Β 

Β 

8.

Estimated cash available for future operating activities

$A'000

8.1

Net cash from / (used in) operating activities (itemΒ 1.9)

(737)

8.2

Β 

8.2a

Payments for exploration & evaluation classified as investing activities (item 2.1(d))

Other (funding of joint venture) (item 2.5)

-

Β 

(2,097)*

8.3

Total relevant outgoings (itemΒ 8.1 + itemΒ 8.2 + item 8.2a)

(2,834)

8.4

Cash and cash equivalents at quarter end (itemΒ 4.6)

12,379

8.5

Unused finance facilities available at quarter end (itemΒ 7.5)

-

8.6

Total available funding (itemΒ 8.4 + itemΒ 8.5)

12,379

8.7

Estimated quarters of funding available (itemΒ 8.6 divided by itemΒ 8.3)

4.4

Note: if the entity has reported positive relevant outgoings (ie a net cash inflow) in itemΒ 8.3, answer itemΒ 8.7 as "N/A". Otherwise, a figure for the estimated quarters of funding available must be included in item 8.7.

* The Company considers it appropriate to include cash outflows related to the funding of joint venture (investing activities) in this table given its ongoing obligation to fund these activities.

8.8

If itemΒ 8.7 is less than 2Β quarters, please provide answers to the following questions:

8.8.1 Does the entity expect that it will continue to have the current level of net operating cash flows for the time being and, if not, why not?

Answer:

Β 

8.8.2 Has the entity taken any steps, or does it propose to take any steps, to raise further cash to fund its operations and, if so, what are those steps and how likely does it believe that they will be successful?

Answer:

Β 

8.8.3 Does the entity expect to be able to continue its operations and to meet its business objectives and, if so, on what basis?

Answer:

Β 

Note: where itemΒ 8.7 is less than 2Β quarters, all of questions 8.8.1, 8.8.2 and 8.8.3 above must be answered.

Β 

Compliance statement

1 This statement has been prepared in accordance with accounting standards and policies which comply with Listing RuleΒ 19.11A.

2 This statement gives a true and fair view of the matters disclosed.

Β 

Β 

Date: 30 October 2020...............................................................

Β 

Β 

Authorised by: By the Audit and Risk Committee...............................

(Name of body or officer authorising release - see noteΒ 4)

Β 

Notes

1. This quarterly cash flow report and the accompanying activity report provide a basis for informing the market about the entity's activities for the past quarter, how they have been financed and the effect this has had on its cash position. An entity that wishes to disclose additional information over and above the minimum required under the Listing Rules is encouraged to do so.

2. If this quarterly cash flow report has been prepared in accordance with Australian Accounting Standards, the definitions in, and provisions of, AASB 6: Exploration for and Evaluation of Mineral Resources and AASB 107: Statement of Cash Flows apply to this report. If this quarterly cash flow report has been prepared in accordance with other accounting standards agreed by ASX pursuant to Listing RuleΒ 19.11A, the corresponding equivalent standards apply to this report.

3. Dividends received may be classified either as cash flows from operating activities or cash flows from investing activities, depending on the accounting policy of the entity.

4. If this report has been authorised for release to the market by your board of directors, you can insert here: "By the board". If it has been authorised for release to the market by a committee of your board of directors, you can insert here: "By the [name of board committee - eg Audit and Risk Committee]". If it has been authorised for release to the market by a disclosure committee, you can insert here: "By the Disclosure Committee".

5. If this report has been authorised for release to the market by your board of directors and you wish to hold yourself out as complying with recommendationΒ 4.2 of the ASX Corporate Governance Council's Corporate Governance Principles and Recommendations, the board should have received a declaration from its CEO and CFO that, in their opinion, the financial records of the entity have been properly maintained, that this report complies with the appropriate accounting standards and gives a true and fair view of the cash flows of the entity, and that their opinion has been formed on the basis of a sound system of risk management and internal control which is operating effectively.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
MSCMZMZGMLNGGZM
Date   Source Headline
12th Oct 20067:15 amRNSDisposal of Danka Europe
28th Sep 20067:45 amRNSAsset Disposal Strategy
27th Sep 20064:41 pmRNSSecond Price Monitoring Extn
27th Sep 20064:36 pmRNSPrice Monitoring Extension
13th Sep 20068:39 amRNSAdditional Listing
5th Sep 20069:57 amRNSBlocklisting Interim Review
31st Aug 20061:30 pmRNSCompletion of Disposal
17th Aug 20062:27 pmRNSIssue of Participating Shares
8th Aug 20061:30 pmRNS1st Quarter Results
17th Jul 20063:00 pmRNSDirectorate Change
3rd Jul 20064:37 pmRNSPrice Monitoring Extension
7th Jun 20061:30 pmRNSFinal Results
31st May 20064:00 pmRNSNotice of Results
25th May 20061:24 pmRNSDirector Declaration
19th May 20061:30 pmRNSDirectorate Change
16th May 200611:54 amRNSIssue of Participating Shares
21st Mar 20065:01 pmRNSDirector Declaration
14th Mar 20066:20 pmRNSDirectorate Change
7th Feb 20061:30 pmRNS3rd Quarter Results
26th Jan 20064:00 pmRNSNotice of Results
17th Jan 20063:00 pmRNSRe Contract
21st Dec 20055:50 pmRNSHolding(s) in Company
21st Dec 20053:42 pmRNSRe Agreement with Kodak
24th Nov 20055:26 pmRNSHolding(s) in Company
16th Nov 20054:19 pmRNSIssue of Participating Shares
10th Nov 20055:30 pmRNSHolding(s) in Company
9th Nov 20055:44 pmRNSResult of AGM
3rd Nov 20051:30 pmRNSInterim Results
28th Oct 20053:04 pmRNSNotice of Results
19th Oct 20053:33 pmRNSBlocklisting Interim Review
17th Oct 20056:07 pmRNSHolding(s) in Company
7th Oct 20053:00 pmRNSDirectorate Change
3rd Oct 20051:30 pmRNSRe MCI Outsourcing Agreement
28th Sep 20053:32 pmRNSHolding(s) in Company
27th Sep 200510:00 amRNSHolding(s) in Company
26th Sep 20057:13 amRNSLatin American Disposals
20th Sep 20055:00 pmRNSAnnual Report and Accounts
8th Sep 20055:21 pmRNSDirectors' Shareholdings
17th Aug 200510:15 amRNSIssue of Participating Shares
16th Aug 20055:51 pmRNSGrant Of Options
16th Aug 20052:01 pmRNSGrant Of Options
3rd Aug 20051:45 pmRNS1st Quarter Results
1st Aug 20053:30 pmRNSGevity Outsourcing Agreement
28th Jul 20053:00 pmRNSNotice of Results
19th Jul 200512:00 pmRNSMCI Outsourcing Agreement
5th Jul 20056:24 pmRNSAppointment of CFO - Amend
5th Jul 20053:30 pmRNSAppointment of CFO
1st Jul 20057:01 amRNSSale of Danka Canada Inc.
10th Jun 20052:41 pmRNSFinal Results - Amendment
10th Jun 20051:34 pmRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.